TheLoneDeranger (talk | contribs) m request for citation |
removed Category:Cannabinoids using HotCat |
||
| Line 54: | Line 54: | ||
{{Cannabinoidergics}} |
{{Cannabinoidergics}} |
||
[[Category:Cannabinoids]] |
|||
[[Category:JWH cannabinoids]] |
[[Category:JWH cannabinoids]] |
||
[[Category:Benzochromenes]] |
[[Category:Benzochromenes]] |
||
Revision as of 16:55, 3 August 2019
 | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C22H32O |
| Molar mass | 312.489 g/mol g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
JWH-133 is a potent selective CB2 receptor agonist with a Ki of 3.4nM and selectivity of around 200x for CB2 over CB1 receptors. It was discovered by and named after, John W. Huffman.
JWH-133, alongside WIN 55,212-2 and HU-210, is responsible for preventing the inflammation caused by Amyloid beta proteins involved in Alzheimer's Disease, in addition to preventing cognitive impairment and loss of neuronal markers [citation needed]. This anti-inflammatory action is induced through agonist action at cannabinoid receptors, which prevents microglial activation that elicits the inflammation. Additionally, cannabinoids completely abolish neurotoxicity related to microglia activation in rat models.[citation needed]
It may be linked with anti-cancer properties, according to pre-trial data from a 2010 study in Madrid.[1]
Legal Status
The substance commonly referred to as "JWH-133" is not a scheduled substance in the U.S, except in Alabama.[2] Low abuse potential makes it less likely for regulation relative to its sister drugs such as JWH-018, as JWH-133 is selective for the non-psychoactive CB2 receptor and thus lacks significant psychoactive effects.[3]
References
- ^ http://www.enewspf.com/index.php/latest-news/health-and-fitness/18029-marijuana-compound-halts-breast-cancer-tumor-growth-
- ^ "Alabama Senate Bill 333 - Controlled substances, Schedule I, additional synthetic controlled substances and analogue substances included in, trafficking in controlled substance analogues, requisite weight increased, Secs. 13A-12-231, 20-2-23 am'd". March 2014. Retrieved 28 September 2015.
- ^ http://www.usdoj.gov/dea/pubs/scheduling.html
External links
- JNeurosci.org Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation Also has been shown to block grown of tumors. More clinical studies and trials are needed.